JP Morgan Chase
MBRX icon

JP Morgan Chase’s Moleculin Biotech MBRX Stock Holding History

JP Morgan Chase’s Portfolio MBRX Stock Details MBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Hold
0
– -$3 – 7598
2024
Q3 		– Hold
0
– – – 7344
2024
Q2 		– Hold
0
– – – 7160
2024
Q1 		– Hold
0
– – – 7073
2023
Q4 		– Hold
0
– – – 7220
2023
Q3 		– Hold
0
– – – 7231
2022
Q2 		– Hold
0
– -$1K – 6708
2022
Q1 		– Hold
0
– – – 6485

Other funds holding MBRX

Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Atticus Wealth Management
Atticus Wealth Management Palm Beach Gardens, Florida $452M AUM 17.19% 1-Year Est. Return